BONE MARROW OSTEOPONTIN AS A PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROME

被引:0
作者
Kim, S. [1 ]
Ji, Y. S. [1 ]
Yun, J. [1 ]
Kim, H. J. [1 ,2 ]
Kim, K. H. [3 ]
Kim, H. J. [1 ,2 ]
Lee, S. C. [2 ]
Bae, S. B. [2 ]
Kim, C. K. [1 ]
Lee, N. S. [3 ]
Lee, K. T. [2 ]
Park, S. K. [1 ]
Won, J. H. [3 ]
Hong, D. S. [1 ]
机构
[1] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Bucheon, South Korea
[2] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Cheonan, South Korea
[3] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1828
引用
收藏
页码:723 / 723
页数:1
相关论文
共 50 条
[31]   Prognostic significance of bone marrow cellularity in myelodysplastic syndromes: a retrospective analysis. [J].
Morita, Kiyomi ;
Ali, Abdullah ;
Coutinho, Diego ;
Mushtaq, Muhammad Umair ;
Raza, Azra .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[32]   High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes [J].
C-L Cheng ;
H-A Hou ;
J-Y Jhuang ;
C-W Lin ;
C-Y Chen ;
J-L Tang ;
W-C Chou ;
M-H Tseng ;
M Yao ;
S-Y Huang ;
B-S Ko ;
S-C Hsu ;
S-J Wu ;
W Tsay ;
Y-C Chen ;
H-F Tien .
British Journal of Cancer, 2011, 105 :975-982
[33]   High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes [J].
Cheng, C-L ;
Hou, H-A ;
Jhuang, J-Y ;
Lin, C-W ;
Chen, C-Y ;
Tang, J-L ;
Chou, W-C ;
Tseng, M-H ;
Yao, M. ;
Huang, S-Y ;
Ko, B-S ;
Hsu, S-C ;
Wu, S-J ;
Tsay, W. ;
Chen, Y-C ;
Tien, H-F .
BRITISH JOURNAL OF CANCER, 2011, 105 (07) :975-982
[34]   ALTERED CELL CYCLE DISTRIBUTION OF BONE MARROW CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS IS ASSOCIATED WITH PROGNOSTIC FEATURES OF THE DISEASE [J].
Matarraz, Sergio ;
Fernandez, Carlos ;
Albors, Manuel ;
Teodosio, Cristina ;
Jara-Acevedo, Maria ;
Lopez, Antonio ;
Gutierrez, Laura ;
Cervero, Carlos ;
Caballero, Gonzalo ;
Gutierrez, Oliver ;
Orfao, Alberto .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) :397-398
[35]   Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome [J].
Leung, W ;
Pitts, N ;
Burnette, K ;
Cunningham, JM ;
Horwitz, EM ;
Benaim, E ;
Hale, G ;
Woodard, P ;
Pui, CH ;
Bowman, LC .
BONE MARROW TRANSPLANTATION, 2001, 27 (07) :717-722
[36]   Myelodysplastic syndrome with monosomy 7 treated by bone marrow transplantation. [J].
Dannawi, H ;
Erickson, D ;
Klein, P .
BLOOD, 1998, 92 (10) :251B-251B
[37]   MYELODYSPLASTIC SYNDROME WITH BONE-MARROW EOSINOPHILIA - CLINICAL AND CYTOGENETIC FEATURES [J].
MATSUSHIMA, T ;
MURAKAMI, H ;
TSUCHIYA, J .
LEUKEMIA & LYMPHOMA, 1994, 15 (5-6) :491-497
[38]   ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME [J].
BANDINI, G ;
ROSTI, G ;
CALORI, E ;
ALBERTAZZI, L ;
TURA, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (03) :442-443
[39]   Hedgehog Pathway Is Deregulated In Myelodysplastic Syndrome Progenitor Bone Marrow Cells [J].
Xavier, Juliana M. ;
Santos Duarte, Adriana Silva ;
Pericole, Fernando V. ;
Latuf-Filho, Paulo ;
Traina, Fabiola ;
Vassallo, Jose ;
Olalla Saad, Sara Teresinha .
BLOOD, 2013, 122 (21)
[40]   Obliterative bronchiolitis in a patient with myelodysplastic syndrome before bone marrow transplantation [J].
Mobeireek, Abdullah ;
Al-Mohareb, Fahad ;
Al-Dayel, Fouad ;
Al-Gazlan, Suliman ;
Alabdely, Hail ;
Khalid, Mohammad .
RESPIRATORY MEDICINE, 2007, 101 (02) :359-362